Honored to receive the Dean’s Award from Palacký University’s Faculty of Medicine for my review on liquid biopsy in monitoring CRPC progression. Grateful for the recognition and support! See the article: www.frontiersin.org/journals/onc... #ProstateCancer #LiquidBiopsy #PalackyUniversity

One week left to apply! Join my lab in beautiful Vienna for your #PhD studying #metastasis.

Juliane Winkler@jwinkler.bsky.social · last yr.

🌟 Exciting #PhD Opportunity! Join my lab in beautiful #Vienna. We are studying tumor-immune interactions in #metastasis using #singlecell and #spatial omics! ⏰ Apply by 04/25 bit.ly/3l7WMhs more infos 👉 winklerlab.org

Thrilled to share our latest study on predicting ARPI therapy failure in metastatic prostate cancer. miR-375 & LMR predict ARPI failure in CRPC. In mHSPC, platelets, CRP & CGA outperform PSA. Toward personalized therapy—guided by blood. #ProstateCancer #Oncology #Biomarkers #LiquidBiopsy

Platelets, Chromogranin A and C-Reactive Protein Predict Therapy Failure of Metastatic Hormone-Sensitive Prostate Cancer while miR-375 Outperforms Prostate-Specific Antigen in Stratifying Castration-R...

Androgen deprivation therapy has long been the first-line treatment for hormone-sensitive prostate cancer (HSPC). After progression to castration-resistant prostate cancer (CRPC), androgen receptor pa...

jmdjournal.org

🌟 Exciting #PhD Opportunity! Join my lab in beautiful #Vienna. We are studying tumor-immune interactions in #metastasis using #singlecell and #spatial omics! ⏰ Apply by 04/25 bit.ly/3l7WMhs more infos 👉 winklerlab.org

Grateful for the opportunity to contribute to prostate cancer research and for all the support along the way — especially from Jan Bouchal and his team at Department of Clinical and Molecular Pathology, Palacký University Olomouc. One step closer to the defense. #ThesisSubmitted#CancerResearch